Quantcast

Latest Pharmaceutical industry in India Stories

2014-06-09 23:07:31

Informative webinar will explore strategic alliances through a case study of the relationship between Infinity Pharmaceuticals and INC Research. The live broadcast will take place on Wednesday, June 25, 2014 at 10:00 EDT (15:00 UK BST/ GMT +1). Toronto, Canada (PRWEB) June 09, 2014 Outsourcing in the clinical development industry has continued to evolve toward partnerships and strategic alliances. This webinar focuses on the relationship between Infinity Pharmaceuticals and INC Research...

2014-06-04 16:25:37

ATLANTA, June 4, 2014 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced its involvement in the Jefferies 2014 Global Healthcare Conference, a four-day global meeting of healthcare industry executives and investors taking place in New York City from June 2-5, 2014. The 2014 Global Healthcare Conference draws 2,500 attendees from more than 300 participating companies and features an extensive range of public & private healthcare...

2014-06-04 12:22:29

Asian Cities To Fuel Economic Expansion, According to Economist Intelligence Unit Report Commissioned by InvestKL LONDON, June 4, 2014 /PRNewswire/ -- In a series of six new reports released Monday to a select audience in London, The Economist Intelligence Unit (EIU) revealed dynamic growth across Asian industries, reinforcing the view that the balance of economic power is shifting eastward. The EIU's "industry dynamism" barometer, commissioned by InvestKL (Greater Kuala Lumpur's investment...

2014-06-02 08:31:48

CRANBURY, N.J., June 2, 2014 /PRNewswire/ -- Ipca Laboratories Ltd., India (Ipca) and Oncobiologics, Inc., USA (Oncobiologics) announced today the creation of a two-part alliance for the development, manufacture and commercialization of biosimilar monoclonal antibody products. Under the first part of the agreement, Ipca will in-license and commercialize biosimilar products for the India and associated markets. These products will be developed by Oncobiologics to US FDA and EU...

2014-06-02 08:30:00

Firm Adds Significantly to Strength of Biotech Investment Team BOSTON, SAN FRANCISCO and LONDON, June 2, 2014 /PRNewswire/ -- SV Life Sciences ("SVLS"), a leading international life sciences venture capital firm, today announced the appointments of Dan Burgess, Dr. Ed Mascioli and Dr. Michael Mendelsohn as new venture partners. All three new venture partners will join SVLS' biotechnology investment team, a highly experienced group investing in truly innovative medicines, platform...

2014-06-02 08:29:05

CALGARY, June 2, 2014 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will participate in the Jefferies 2014 Global Healthcare Conference in a session on Tuesday June 3(rd), 2014 at 4:00 p.m. ET. The conference takes place from June 2(nd) to 5(th) in New York, NY. A live audio link to the webcast session will be available at: http://wsw.com/webcast/jeff82/ONCY or on the company's website at...

2014-05-28 20:20:50

LONDON, May 28, 2014 /PRNewswire/ -- Imperial Innovations Group plc (AIM:IVO, 'Innovations'), the leading technology commercialisation and investment company and S.R.One Ltd, GlaxoSmithKline's venture captial fund, announce today that they have led, alongside co-investor UCL Business PLC (UCLB), an GBP850,000 seed financing for Puridify, a newly formed company providing purification solutions for biotherapeutic manufacturing. Puridify's technology was developed in the...

2014-05-27 12:32:32

LONDON, May 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Diabetic Nephropathy Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/diseases/global_diabetic_nephropathy_market_2014_2018.html About Diabetic NephropathyDiabetic nephropathy is a disease of the kidney glomerulus, which is caused by high blood sugar. When diabetes damages kidneys, which contain millions of tiny blood vessel clusters (glomeruli) that filter waste from the...

2014-05-27 08:28:11

NESS ZIONA, Israel, May 27, 2014 /PRNewswire/ -- Mapi Pharma Ltd. ("Mapi" or the "Company"), a developer of high-barrier to entry and high value-added generic drugs, announced today that its US patent for the company's Glatiramer Acetate Depot has been extended until December 2030. The notice of allowance for US Patent Application No. 13/258,808 entitled Depot Systems Comprising Glatiramer or Pharmacologically Acceptable Salt Thereof, also awarded additional claims to...

2014-05-23 04:20:53

LONDON, May 23, 2014 /PRNewswire/ -- New Company Created to be a Leading Provider of Technologies and Services to Enable Better Biopharmaceuticals - PolyTherics and Antitope to continue to trade as wholly owned subsidiaries of Abzena - New brand highlights depth and range of offering to the global biopharmaceutical industry - Abzena to establish headquarters in Cambridge, UK PolyTherics Limited ("PolyTherics"), a...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related